CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study
Background: Despite their potential usefulness as biomarkers, no study has investigated the interactions between cerebrospinal fluid (CSF) changes of neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), growth differentiation factor 15 (GDF-15), transactive response DNA binding p...
Saved in:
| Main Authors: | Domenico Plantone, Matteo Pardini, Carlo Manco, Delia Righi, Paolo Alessandro Alì, Dario Arnaldi, Virginia Pelagotti, Federico Massa, Miriana d’Alessandro, Elena Bargagli, Nicola De Stefano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864251314773 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot–Marie Tooth patients
by: Dace Pretkalnina, et al.
Published: (2025-01-01) -
Clinical applications and diagnostic research of GFAP and NfL in MS and NMOSD: a meta-analysis
by: XueJuan Lin, et al.
Published: (2025-07-01) -
Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson’s disease subtypes
by: Shiyu Li, et al.
Published: (2025-03-01) -
The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
by: Sara Samadzadeh, et al.
Published: (2025-03-01) -
Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD
by: Patrick Schindler, et al.
Published: (2025-07-01)